Thomas Filleron
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers 24
- Colorectal Cancer Treatments and Studies 14
- Cancer Treatment and Pharmacology 13
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 26
- Immunology top 2%
-
- Lung Cancer Treatments and Mutations 33
- Sarcoma Diagnosis and Treatment 16
- Genetics top 5%
-
- Statistical Methods in Clinical Trials 25
-
- Health Systems, Economic Evaluations, Quality of Life 13
- Co-authors
- Philippe RochaixSophie Le GuellecLudovic MartinetIgnacio GarridoJean‐Philippe GirardJulia GilhodesNicolás MeyerJean‐Jacques Fournié
- Cited by
- OncologyCancer ResearchImmunology
- Journals
- Nature Communications (2 papers)Journal of Clinical Oncology (14 papers)The Journal of Immunology (1 paper)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Thomas Filleron
206 papers receiving 4.9k citations
Peers
Comparison fields: 5 of 141
- Oncology 2.1k
- Cancer Research 808
- Immunology 958
- Pulmonary and Respiratory Medicine 1.4k
- Genetics 298
Countries citing papers authored by Thomas Filleron
This map shows the geographic impact of Thomas Filleron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Filleron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Filleron more than expected).
Fields of papers citing papers by Thomas Filleron
This network shows the impact of papers produced by Thomas Filleron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Filleron. The network helps show where Thomas Filleron may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Filleron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 5 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 1 | |
| 8 | 2020 | 70 | |
| 9 | 2019 | 18 | |
| 10 | 2018 | 26 | |
| 11 | 2018 | 28 | |
| 12 | 2017 | 21 | |
| 13 | 2016 | 11 | |
| 14 | 2015 | 2 | |
| 15 | 2015 | 219 | |
| 16 | 2014 | 18 | |
| 17 | 2011 | 387 | |
| 18 | 2010 | 20 | |
| 19 | 2010 | 21 | |
| 20 | 2010 | 27 |
About Thomas Filleron
Thomas Filleron is a scholar working on Oncology, Statistics and Probability and Cancer Research, having authored 222 papers that have together received 4.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (33 papers), Cancer Genomics and Diagnostics (26 papers), Statistical Methods in Clinical Trials (25 papers), Cancer Immunotherapy and Biomarkers (24 papers), Sarcoma Diagnosis and Treatment (16 papers), Colorectal Cancer Treatments and Studies (14 papers), Health Systems, Economic Evaluations, Quality of Life (13 papers) and Cancer Treatment and Pharmacology (13 papers). The work is most often cited by research in Oncology (2.1k citations), Cancer Research (808 citations) and Immunology (958 citations). Thomas Filleron has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Philippe Rochaix, Sophie Le Guellec, Ludovic Martinet, Ignacio Garrido, Jean‐Philippe Girard, Julia Gilhodes, Nicolás Meyer, Jean‐Jacques Fournié, Elisabeth Bellard and Florence Dalenc. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.